Vimarsana
Biggest News Aggregation in the World

Herb Aronow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Herb Aronow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Herb Aronow Today - Breaking & Trending Today

Heart attack breakthrough: New protocol saves 71% of patients with deadly complication - Vimarsana News

Heart attack breakthrough: New protocol saves 71% of patients with deadly complication

Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Health, in collaboration with 80 hospitals nationwide.

National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival - Vimarsana News

National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival

Protocol developed by Henry Ford Health cardiologists leading unprecedented nationwide research.

Medical professionals raise awareness about artificial sweeteners as heart attack, stroke risk increase - Vimarsana News

Medical professionals raise awareness about artificial sweeteners as heart attack, stroke risk increase

Medical professionals in Michigan are raising awareness about artificial sweeteners as the risk of a heart attack or stroke has increased.

Why one Detroit-area doctor says he's done using this artificial sweetener - Vimarsana News

Why one Detroit-area doctor says he's done using this artificial sweetener

Medical professionals in Michigan are raising awareness about artificial sweeteners as the risk of a heart attack or stroke has increased.

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease - Vimarsana News

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease

Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas.